Skip to main content
. 2023 Jun 19;16:106. doi: 10.1186/s13104-023-06379-y

Table 6.

Correlation between age group and antibiotic resistance profile among Gram-negative samples

Antibiotic Resistance profile P-value*
Sensitive Intermediate Resistant
Ticracillin / Tazobactam

1–20

20–40

41–60

2

0

3

13

4

3

8

11

9

0.065
Tigycyclin

1–20

20–40

41–60

3

2

6

11

10

5

9

3

4

0.157
Chloramphenicol

1–20

20–40

41–60

7

7

7

4

2

2

12

6

6

0.838
Cefuroxime

1–20

20–40

41–60

4

0

2

3

3

1

16

12

12

0.448
Cefazolin

1–20

20–40

41–60

0

0

0

0

0

0

23

15

15

 N/A
Imipineme

1–20

20–40

41–60

10

4

5

3

2

5

10

9

5

0.369
Gentamycin

1–20

20–40

41–60

12

5

9

2

2

1

9

8

5

0.677
Ampicillin / Sulbactam

1–20

20–40

41–60

3

0

1

4

0

1

16

15

13

0.185
Amoxicillin/ Clavulanic

1–20

20–40

41–60

3

1

2

2

2

5

18

12

8

0.309
Ceftazidime

1–20

20–40

41–60

0

0

1

5

1

1

18

14

13

0.285
Levofloxacin

1–20

20–40

41–60

19

8

8

0

2

1

4

5

6

0.171
Ciprofloxacin

1–20

20–40

41–60

17

5

8

1

4

1

5

6

6

0.077
Trimethoprim / Sulfamethoxazole

1–20

20–40

41–60

6

5

3

5

3

3

12

8

8

0.942

*Chi square test; P-value was set to 0.05; N/A: not applicaple